Sterility
KIRO® Oncology
“Evaluation of the efficacy of a self-cleaning automated compounding system for the decontamination of cytotoxic drugs(25)”
✓
Two dilutions (0,6mg/mL and 60 mg/mL) of 9 different cytotoxic drugs *1 per dilution were added to the KIRO® Oncology’s compounding area surface.
✓
The dilutions correspond to two levels of surface contamination D1 (1ng/cm2) and D100 (100ng/cm2).
✓
Contamination levels were determined, with a surface wipe sampling kit.
✓
Six days over a three-week period in an oncology health center.
This study demonstrated that KIRO® Oncology self-cleaning system:
✓
Has a decontamination efficacy of 99.8% or greater for nine cytotoxic drugs*1 commonly used.
✓
Is an effective unique solution for avoiding daily manual cleaning tasks of a compounding robot.
*1Cytotxic drugs commonly used: 5-flurorouracil, ifosfamide, cyclophosphamide, gemcitabine, etoposide, methotrexate, paclitaxel, docetaxel and carboplatin
